Pneumocystis pneumonia following rituximab

Chest

Volumn 145, Issue 3, 2014, Pages 663-664

  Farkas, Joshua D ^a   Clouser, Ryan D ^a   Garrison, Garth W ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB; STEROID;

BACTERIAL COLONIZATION; DISEASE PREDISPOSITION; FALSE POSITIVE RESULT; FLUORESCENCE MICROSCOPY; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; LETTER; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; OPPORTUNISTIC INFECTIONS; PNEUMONIA, PNEUMOCYSTIS;

EID: 84896800123     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-2539     Document Type: Letter

References (2)

1. Martin-Garrido I , Carmona EM , Specks U , Limper AH. Pneumocystis pneumonia in patients treated with rituximab. Chest. 2013 ; 144 (1): 258-265.
2. Wilson JW , Limper AH , Grys TE , Karre T , Wengenack NL , Binnicker MJ. Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity. Diagn Microbiol Infect Dis. 2011; 69 (2): 145-152.